Carregant...
DiaRem2: Incorporating duration of diabetes to improve prediction of diabetes remission following metabolic surgery
BACKGROUND: DiaRem is a validated tool for predicting the likelihood of type 2 diabetes (T2DM) remission after Roux-en-Y gastric bypass (RYGB) surgery. OBJECTIVES: The objective of this study is to determine if the addition of duration of T2DM to DiaRem improves its ability to discriminate between p...
Guardat en:
| Publicat a: | Surg Obes Relat Dis |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589131/ https://ncbi.nlm.nih.gov/pubmed/30686670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.soard.2018.12.020 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|